| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 03/13/2013 | CN102964308A Novel pyrimidine compound, preparation method thereof, pharmaceutical composition containing novel pyrimidine compound and application of novel pyrimidine compound |
| 03/13/2013 | CN102964232A Preparation method of ketone compound and its derivatives |
| 03/13/2013 | CN102964193A Method for synthesizing nitrosoureas antineoplastic drugs through stannic chloride-sodium nitrite system |
| 03/13/2013 | CN102311393B Preparation method of sulfadoxine |
| 03/13/2013 | CN102267950B Oxime ether dichloro-allyl ether compounds with insecticidal activity |
| 03/13/2013 | CN101906076B Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof |
| 03/13/2013 | CN101277948B Chemical process |
| 03/12/2013 | US8394956 Process for preparing pyrimidine propenaldehyde |
| 03/12/2013 | US8394955 2,4 (4,6) pyrimidine derivatives |
| 03/12/2013 | US8394954 Benzophenone hybrids as anticancer agents and processes for the preparation thereof |
| 03/12/2013 | US8394953 Compounds and methods for enzyme-mediated tumor imaging and therapy |
| 03/12/2013 | US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/12/2013 | US8394807 Quinazoline inhibitors of BACE 1 and methods of using |
| 03/12/2013 | US8394806 2-phenyl pyrazines as tubulin inhibitors |
| 03/12/2013 | US8394786 Quinazoline derivatives |
| 03/12/2013 | CA2569763C 2,4-diaminoquinazolines for spinal muscular atrophy |
| 03/12/2013 | CA2566917C Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 03/07/2013 | WO2013033068A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/07/2013 | WO2013033003A1 Hiv replication inhibitors |
| 03/07/2013 | WO2013032522A1 Pyrimidine carboxamide derivatives |
| 03/07/2013 | WO2013030777A1 Co-crystals of cyprodinil and dithianon |
| 03/07/2013 | WO2013029555A1 Lavendustin a derivatives, preparation method and use thereof |
| 03/07/2013 | WO2013004995A8 Pyrimidinone compounds and their use |
| 03/07/2013 | US20130060032 Potassium fluoride dispersion and process for producing fluorine-containing organic compound using the same |
| 03/07/2013 | US20130060031 Process for the preparation of highly pure ambrisentan |
| 03/07/2013 | US20130060029 Quinazolinone derivatives useful as vanilloid antagonists |
| 03/07/2013 | US20130060028 Novel processes |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059864 Inhibiting neurotransmitter reuptake |
| 03/07/2013 | US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| 03/07/2013 | DE4416256B4 Partiell fluorierte Benzolderivate und flüssigkristallines Medium Partially fluorinated benzene derivatives and liquid crystalline medium |
| 03/07/2013 | CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 03/07/2013 | CA2844119A1 Hiv replication inhibitors |
| 03/07/2013 | CA2844014A1 Co-crystals of cyprodinil and dithianon |
| 03/06/2013 | EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/06/2013 | EP2563777A2 Inverse agonists and neutral antagonists for the tsh receptor |
| 03/06/2013 | EP2563362A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites |
| 03/06/2013 | EP2563129A1 N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives |
| 03/06/2013 | CN102952539A Molecular sensor with Cu<2+> recognition function and preparation method thereof |
| 03/06/2013 | CN102952146A Heterocyclic compound, organic light-emitting device, and flat display device |
| 03/06/2013 | CN102952087A Quinazoline ring contained ether compound and its use |
| 03/06/2013 | CN102952086A Preparation method of 2-morpholinyl-substituted pyrimidine compounds |
| 03/06/2013 | CN102952085A Synthesis method of 2-(2-(6-(2-cyanophenoxy) pyrimidin-4-oxy) phenyl) methyl acetate |
| 03/06/2013 | CN102952084A Synthesis method of 4, 6-dichloro-2-methylthio-5-nitro pyrimidine |
| 03/06/2013 | CN102952083A Preparation method of 2-amino pyrimidine |
| 03/06/2013 | CN102952082A Manual synthetic method for tetrahydropyrimidine hydrochloride |
| 03/06/2013 | CN102015627B Amide compounds, preparation methods and uses thereof |
| 03/06/2013 | CN101583604B Synthesis of 4-amino-pyrimidines |
| 03/06/2013 | CN101098859B Pyrimidinone compound, preparation and application thereof |
| 03/05/2013 | US8389734 Amides useful as inhibitors of voltage-gated sodium channels |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389718 Insecticidal triazines and pyrimidines |
| 03/05/2013 | US8389538 Rexinoid compound having alkoxy group |
| 03/05/2013 | US8389533 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors |
| 03/05/2013 | US8389532 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine |
| 03/05/2013 | US8389531 Process for erlotinib hydrochloride |
| 03/05/2013 | US8389521 Inhibitors of protein kinases |
| 03/05/2013 | US8389516 Antibacterial compositions |
| 02/28/2013 | WO2013028590A1 Pyrimidine pde10 inhibitors |
| 02/28/2013 | WO2013027846A1 Light-emitting element, light-emitting device, electronic device, lighting device, and novel organic compound |
| 02/28/2013 | WO2013027660A1 Pesticide |
| 02/28/2013 | WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors |
| 02/28/2013 | WO2013026391A1 Synthesis method of azoxystrobin and exclusive intermediate in the synthesis thereof |
| 02/28/2013 | WO2010076810A3 A process for the preparation of gefitinib |
| 02/28/2013 | US20130053408 Methods and compositions utilizing quinazolinones |
| 02/28/2013 | US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 02/28/2013 | US20130053343 Compounds and methods for inhibiting serotonin synthesis |
| 02/28/2013 | US20130048964 Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Novel Organic Compound |
| 02/27/2013 | EP2562167A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562166A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562165A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562164A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562163A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562162A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562161A1 5-fluoro pyrimidine derivatives as fungicides |
| 02/27/2013 | EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 02/27/2013 | CN1886385B Crystals of phenylalanine derivatives and production methods thereof |
| 02/27/2013 | CN102942529A 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound as well as preparation method and application of 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound |
| 02/27/2013 | CN102942500A Preparation method of N-formamide compound |
| 02/27/2013 | CN102942429A Method for preparing aza or thia aryl biaryl compound by aid of palladium and carbon catalysts |
| 02/27/2013 | CN101627017B Process for the manufacture of a precursor of vitamin b1 |
| 02/27/2013 | CN101346336B 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 02/27/2013 | CN101268058B 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/26/2013 | US8383824 Heterocyclic antiviral compounds |
| 02/26/2013 | US8383813 Fused pyrrolocarbazoles |
| 02/26/2013 | US8383641 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 02/26/2013 | US8383638 Aminobenzoquinazolinone M1 receptor positive allosteric modulators |
| 02/26/2013 | US8383637 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 02/26/2013 | US8383627 Crystalline polymorph of doxazosin mesylate (form IV) and process for preparation thereof |
| 02/26/2013 | CA2572544C Modified pyrimidine glucocorticoid receptor modulators |
| 02/26/2013 | CA2542076C Substituted tricyclic compounds as protein kinase inhibitors |
| 02/21/2013 | WO2013025796A2 N-(5-fluoro-2((4-methylbenzyl)oxy)pyrimidin-4-yl) benzamide derivatives |
| 02/21/2013 | WO2013025508A1 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infections |
| 02/21/2013 | WO2013024005A1 Anthranilamide compounds and their use as pesticides |
| 02/21/2013 | WO2013024003A1 N-thio-anthranilamide compounds and their use as pesticides |
| 02/21/2013 | WO2013023300A1 Inhibitors of androgen receptor activation function-2 (af2) as therapeutics and methods for their use |
| 02/21/2013 | US20130045985 N-(5-fluoro-2-((4-methylbenzyl)oxy)pyrimidin-4-yl)benzamide derivatives |
| 02/21/2013 | US20130045984 5-fluoro-4-imino-3,4-dihydropyrimidin-2-(1h)-ones derivatives |
| 02/21/2013 | US20130045972 Glucocorticoid receptor antagonists |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |